VP, Chief Medical Officer
Medtronic
Leiden, Netherlands
Pieter Kappetein, MD, PhD, is since 2017 Chief Medical Officer and Vice-President of Coronary, Structural Heart, Cardiac Surgery and Mechanical Circulatory Support of Medtronic. In November 2020 he was also appointed Vice-President of Clinical and Medical Science Europe, Middle East and Africa (EMEA).
Before joining Medtronic, Pieter was a Consultant Cardiothoracic Surgeon and Professor at the Thoraxcenter at the Erasmus Medical Center in Rotterdam, The Netherlands. He was Secretary General of the European Association for Cardio-thoracic Surgery for 9 years, President of CTSnet and member of the Board of the Society of Thoracic Surgeons and chairman of the International Cooperation committee of the STS in the USA.
Besides this he was member of the Editorial Board of the Annals of Thoracic Surgery and Eurointervention. His clinical interests include valve surgery, indications, outcome and innovations in transcatheter aortic and mitral valve replacement and repair, coronary surgery and mechanical circulatory support He is interested in education, and epidemiology. He was co-principal investigator of the SYNTAX and EXCEL trial (comparing coronary surgery with drug eluting stents) and member of the steering committee of the SURTAVI trial on percutaneous valves and the RESHAPE trial: the evaluation of the Mitraclip in patients with heart failure. He was also member of the steering committee of the Re-align trial on Dabigatran in patients with mechanical heart valves.
He was also advisor and member of an R&D team for a novel sternal closure device.
He served as project leader of the ‘One valve for life” research program, a study together with the Technical University in Eindhoven and the University Hospital in Utrecht, developing a tissue engineered heart valve.
Several start-up companies worked with him in order to define their clinical strategy.
Innovation, Evidence & Outcomes: Penditure™ LAA Exclusion System and Avalus ™ Bioprosthesis
Saturday, January 27, 2024
11:25 AM – 12:25 PM CT